diabetic polyneuropathy. Type 2 diabetes mellitus with diabetic polyneuropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with type 2 diabetes and confirmed diabetic peripheral neuropathy based on clinical criteria (sensory-motor symptoms in the lower limbs), pin-prick test, and significant pain score on the VAS scale, whose diabetic medication (oral/insulin) has been stable without major dose changes for at least 3 months, have quality of life impairment related to Michigan Neuropathy Screening Instrument (MNSI) and Norfolk QOL-DN questionnaires, possess independent mobility capability and regular attendance at treatment sessions, and provide written informed consent, are eligible for study entry (no age restriction)
Exclusion criteria
Exclusion criteria: Type 2 diabetes mellitus Confirmed diabetic peripheral neuropathy based on clinical criteria Sensory-motor symptoms in the lower limbs.Positive pin-prick test result Significant pain score on VAS scale Impaired quality of life on Michigan Neuropathy Screening Instrument (MNSI).Impaired quality of life on Norfolk QOL-DN questionnaire Independent mobility capability (with/without simple assistive device).Ability to attend 12 treatment sessions regularly
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity score measured by Visual Analog Scale (VAS). Timepoint: At the begining of the study and four weeks after the interventions. Method of measurement: Clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences